Home / Market News / $AMRZ

$AMRZ news and market catalysts

The 26 most recent market catalysts affecting $AMRZ, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

26 catalysts 2 high impact 4 bullish 15 bearish Building Materials
Nov 16, 2026 Corporate Catalyst Neutral Impact 55
UBS Initiates Coverage on Amrize with Hold Rating
UBS has initiated coverage on Amrize Ltd., a building materials company, assigning it a 'Hold' rating and a $46 price target. This event is significant as it marks the formal entry…
Nov 16, 2026 Corporate Catalyst Bullish Impact 55
UBS Adjusts Price Target on Amrize to $46 From $42
UBS has adjusted its price target for Amrize Ltd. upwards from $42 to $46. This change reflects an updated analyst assessment of the company's market position and valuation, sugges…
Nov 9, 2026 Corporate Catalyst Bearish Impact 65
Berenberg Bank Downgrades Amrize to Hold
Berenberg Bank downgraded Amrize to a 'Hold' rating from 'Buy' and reduced its price target from $48 to $46. This action stems from specific concerns regarding the performance and …
Nov 2, 2026 Corporate Catalyst Bearish Impact 55
Oppenheimer Adjusts Amrize Price Target to $52 From $55
Oppenheimer, a prominent investment bank, has adjusted its price target for Amrize (AMRZ) from $55 to $52. This revision signals a slightly tempered outlook on the company's future…
Oct 30, 2026 Corporate Catalyst Bullish Impact 55
DA Davidson Maintains Amrize at Neutral, Raises Price Target to $43
DA Davidson, an investment bank, has updated its coverage on Amrize Ltd., raising its price target by 7.5% to $43 while keeping a 'Neutral' rating. This indicates a slightly more o…
Oct 30, 2026 Corporate Catalyst Bearish Impact 65
Berenberg Bank Adjusts Price Target on Amrize to $48 From $64
Berenberg Bank adjusted its price target for Amrize shares down to $48 from $64, a substantial 25% reduction. This action comes after Amrize's recent third-quarter financial report…
Oct 28, 2026 Corporate Catalyst Bullish Impact 65
Amrize Ltd Completes $1 Billion Share Repurchase Program
Amrize Ltd has completed its previously announced $1 billion share repurchase program, acquiring 22.4 million shares. This action reduces the outstanding share count by nearly 4%, …
Oct 28, 2026 Corporate Catalyst Neutral Impact 92
Amrize Ltd Reports Q3 2026 Financial Results
Amrize Ltd's Q3 2026 earnings report presents a nuanced picture for investors. The revenue miss, while not catastrophic, suggests that the company may be facing headwinds in sales …
Oct 28, 2026 Corporate Catalyst Bearish Impact 75
Amrize Ltd Updates 2026 Revenue Guidance
Amrize Ltd's 8-K filing reveals a downward revision to its 2026 revenue guidance, now expecting $12.2 billion to $12.4 billion, which falls short of the $12.51 billion FactSet cons…
Oct 19, 2026 Corporate Catalyst Neutral Impact 55
Barclays Maintains Equal-Weight on Amrize, Lowers Price Target to $40
Barclays analyst Adam Seiden has reduced the price target for Amrize (AMRZ) from $55 to $40, signaling a more cautious valuation outlook. While the 'Equal-Weight' rating suggests t…
Oct 13, 2026 Corporate Catalyst Bearish Impact 55
JP Morgan Maintains Neutral on Amrize, Lowers Price Target to $48
JP Morgan's analyst Adrian Huerta has maintained a 'Neutral' rating on Amrize but lowered the price target from $52 to $48. This action signals a slightly reduced valuation expecta…
Oct 9, 2026 Corporate Catalyst Bearish Impact 65
RBC Capital Maintains Underperform on Amrize, Lowers Price Target to $32
RBC Capital analyst Anthony Codling has maintained an 'Underperform' rating on Amrize (AMRZ) and cut the price target from $48 to $32. This significant reduction in the price targe…
Oct 1, 2026 Corporate Catalyst Neutral Impact 60
Barclays Initiates Coverage On Amrize with Equal-Weight Rating, Announces Price Target of $55
Barclays analyst Adam Seiden has initiated coverage on Amrize (AMRZ) with an 'Equal-Weight' rating and a $55 price target. This event is significant as new analyst coverage, especi…
Sep 22, 2026 Corporate Catalyst Bearish Impact 65
UBS Maintains Neutral on Amrize, Lowers Price Target to $42
UBS analyst Julian Radlinger has revised their price target for Amrize (AMRZ) down to $42 from $57, while keeping a 'Neutral' rating. This substantial 26% reduction in the price ta…
Sep 18, 2026 Corporate Catalyst Bearish Impact 55
Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $55
Oppenheimer analyst Bryan Blair maintained an 'Outperform' rating on Amrize (AMRZ) but lowered the price target from $62 to $55. This indicates that while the analyst still sees lo…
Sep 9, 2026 Corporate Catalyst Bearish Impact 65
Wells Fargo Downgrades Amrize to Equal-Weight, Lowers Price Target to $44
Wells Fargo analyst Timna Tanners downgraded Amrize (AMRZ) from 'Overweight' to 'Equal-Weight' and lowered the price target from $55 to $44. This action indicates a revised, less o…
Sep 2, 2026 Corporate Catalyst Bearish Impact 65
JP Morgan Downgrades Amrize to Neutral, Lowers Price Target to $52
JP Morgan analyst Adrian Huerta downgraded Amrize (AMRZ) from Overweight to Neutral and lowered the price target from $57 to $52. This action indicates a revised, less optimistic v…
Sep 2, 2026 Corporate Catalyst Bearish Impact 65
B of A Securities Downgrades Amrize to Underperform, Lowers Price Target to $40
BofA Securities analyst Arnaud Lehmann downgraded Amrize (AMRZ) from Neutral to Underperform and lowered the price target from $50 to $40. This action indicates a revised, more pes…
Aug 25, 2026 Corporate Catalyst Neutral Impact 55
DA Davidson Initiates Coverage On Amrize with Neutral Rating, Announces Price Target of $50
DA Davidson's initiation of coverage on Amrize with a Neutral rating and a $50 price target provides a new data point for investors. This is a moderate catalyst as it introduces a …
Aug 24, 2026 Corporate Catalyst Neutral Impact 65
Amrize Appoints Samuel J. Poletti CFO, Effective Immediately, Succeeding Baris Oran
Amrize has appointed Samuel J. Poletti as its new CFO, replacing Baris Oran who is departing for personal reasons. This is a significant leadership change in a critical executive p…
Aug 10, 2026 Corporate Catalyst Bearish Impact 75
RBC Capital Downgrades Amrize to Underperform, Lowers Price Target to $48
RBC Capital analyst Anthony Codling downgraded Amrize (AMRZ) from 'Sector Perform' to 'Underperform' and significantly lowered the price target from $60 to $48. This action indicat…
Aug 7, 2026 Corporate Catalyst Bearish Impact 75
Amrize shares are trading lower after the company reported mixed Q2 financial results.
This headline directly impacts Amrize (AMRZ) as it reflects immediate investor reaction to their Q2 earnings. 'Mixed results' often mean some metrics beat expectations while others…
Aug 6, 2026 Corporate Catalyst Bearish Impact 75
Amrize shares are trading lower after the company reported mixed Q2 financial results.
The headline indicates a direct corporate catalyst impacting Amrize. 'Mixed' results often mean some metrics beat expectations while others missed, leading to investor uncertainty …
Aug 6, 2026 Corporate Catalyst Bullish Impact 92
Amrize Q2 Adj. EPS $0.88 Misses $0.94 Estimate, Sales $3.494B Beat $3.365B Estimate
Amrize's Q2 earnings report presents a mixed picture. While the company successfully beat revenue expectations, indicating strong top-line growth, the miss on adjusted EPS suggests…
Jul 21, 2026 Corporate Catalyst Bearish Impact 55
Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $65
Oppenheimer analyst Bryan Blair maintained an 'Outperform' rating on Amrize (AMRZ) but lowered the price target from $68 to $65. This action signals that while the analyst still be…
Jul 20, 2026 Corporate Catalyst Neutral Impact 55
Amrize Enters Agreement To Acquire Rapid Redi-Mix; Terms Not Disclosed
This acquisition is a corporate catalyst primarily affecting the construction materials sector. While the terms are undisclosed, Amrize (AMRZ) is likely to benefit from increased m…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.